PERL concludes reduced uric acid has no impact on kidney disease in type 1 diabetes

(Joslin Diabetes Center) Three years of sustained reductions of blood levels of uric acid with the generic drug allopurinol did not benefit type 1 diabetes patients with mild to moderate kidney disease.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news